The Association Between Plasma Fatty Acids and Risk of Lung Cancer: A Prospective Cohort Study of the UK Biobank
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae609 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Jianv Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Fatty Acids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences, National Natural Science Foundation of China, Jiangsu Natural Science Foundation.
Abstract (Originalsprache)
Context
Fatty acids (FAs) have emerged as significant contributors to tumorigenesis, yet prospective evidence regarding their specific effects on lung cancer risk remains scarce.
Objective
To investigate the association between plasma FAs and lung cancer incidence, as well as a potential modification effect of genetic susceptibility on lung cancer risk.
Methods
A cohort study was conducted involving 112 547 cancer-free participants from the UK Biobank, with measurements of plasma FAs, including saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), and polyunsaturated fatty acids (PUFAs), at baseline (2006-2010). Cox regression models were employed to assess lung cancer risk according to plasma FA quartiles or 1-SD increments. Furthermore, interaction between plasma FAs and polygenic risk score was evaluated using an additive model.
Results
Over an average 10.9-year follow-up, 1122 lung cancer cases occurred. After multivariable adjustment, MUFAs were positively associated with lung cancer risk (hazard ratio [HR] per 1-SD = 1.32; 95% CI, 1.13-1.54). In contrast, PUFAs, particularly n-3 PUFAs, n-6 PUFAs, docosahexaenoic acid, and linoleic acid, were associated with a lower risk of lung cancer, with HRs ranging from 0.79 (95% CI, 0.72-0.87) to 0.89 (95% CI, 0.83-0.95). SFAs were not significantly associated with lung cancer risk. Moreover, we observed an additive interaction between plasma PUFAs and genetic risk. Individuals with a high genetic risk and the lowest quartile of plasma PUFAs had the highest risk of lung cancer (HR = 2.20, 95% CI, 1.43-3.38).
Conclusion
Our findings suggest that plasma PUFAs may serve as protective factors, while MUFAs represent risk factors for lung cancer, offering novel insights into lung cancer carcinogenesis and prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
- Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Gusu School, Nanjing Medical University, Nanjing 211166, China.
ORCID-Profile: Meng Zhu, Hongxia Ma, Dong Hang, Hongbing Shen
Förderung
- Chinese Academy of Medical Sciences
- National Natural Science Foundation of China
- Jiangsu Natural Science Foundation
Zitieren
APA
Huang, J., Li, J., He, L., Miao, J., Zhu, M., Dai, J., Jin, G., Ma, H., Hang, D., & Shen, H. (2025). The Association Between Plasma Fatty Acids and Risk of Lung Cancer: A Prospective Cohort Study of the UK Biobank. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae609
Vancouver
Huang J, Li J, He L, Miao J, Zhu M, Dai J, et al. The Association Between Plasma Fatty Acids and Risk of Lung Cancer: A Prospective Cohort Study of the UK Biobank. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae609
BibTeX
@article{Huang2025,
author = {Huang, Jianv and Li, Jiacong and He, Lu and Miao, Junyan and Zhu, Meng and Dai, Juncheng and Jin, Guangfu and Ma, Hongxia and Hang, Dong and Shen, Hongbing},
title = {The Association Between Plasma Fatty Acids and Risk of Lung Cancer: A Prospective Cohort Study of the UK Biobank},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae609}
}
EUVIMED